Literature DB >> 3411340

Skeletal complications in hairy cell leukemia: diagnosis and therapy.

B C Lembersky1, M J Ratain, H M Golomb.   

Abstract

We identified eight patients with skeletal complications associated with hairy cell leukemia (HCL). The median time from diagnosis of HCL to the diagnosis of skeletal complications was 20 months (range, 0 to 93). All patients complained of pain and all but one lesion were located in the axial skeleton, primarily the proximal femur. Lytic lesions were seen on radiographic examination in all but one patient, and one patient additionally had multiple osteoporotic vertebral compression fractures. Radionuclide technetium bone scan was abnormal in all patients examined. Although the peripheral blood counts were variable (only two patients had a leukemic phase of the disease), all patients examined had a hypercellular bone marrow biopsy with hairy cells comprising at least 90% of the hematopoietic elements. The skeletal abnormalities responded well to local radiation therapy. Seven patients were begun on systemic therapy with interferon alpha-2b after the diagnosis of the skeletal lesion. Four of five evaluable patients had a partial hematological response and a substantial improvement in the degree of hairy cell infiltration of the bone marrow. None of these patients has had a recurrence of skeletal complications at a median follow-up time of 29 months. One patient failed to respond hematologically and developed additional bone lesions after 1 year of treatment. Another patient developed a new skeletal lesion 3 months after the cessation of interferon therapy at which time the bone marrow was essentially packed with hairy cells. This retrospective study indicates that bone involvement is a rare complication of HCL and is associated with a high tumor burden in the bone marrow. In addition to local radiation therapy, systemic treatment with interferon should be considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411340     DOI: 10.1200/JCO.1988.6.8.1280

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

1.  Pathologic fracture occurring 22 years after diagnosis of hairy cell leukemia: case report and literature review.

Authors:  K S Snell; M M O'Brien; K Sendelbach; R Martino
Journal:  West J Med       Date:  1999-03

2.  Extensive infiltration of bone with marrow necrosis in a case of hairy cell leukaemia.

Authors:  J Hudson; M Cobby; P Yates; I Watt
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

3.  Hairy cell leukemia presenting with a lytic bone lesion.

Authors:  Naresh Pemmaraju; Javed Gill; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

Review 4.  The optimal management of hairy cell leukaemia.

Authors:  R Gollard; T C Lee; L D Piro; A Saven
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.

Authors:  Evan A Farkash; Judith A Ferry; Nancy Lee Harris; Ephraim P Hochberg; Ronald W Takvorian; Dan S Zuckerman; Aliyah R Sohani
Journal:  J Hematop       Date:  2009-08-20       Impact factor: 0.196

6.  Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature.

Authors:  Ipek Yonal-Hindilerden; Fehmi Hindilerden; Sanem Bulut-Dereli; Eren Yıldız; Ibrahim Oner Dogan; Meliha Nalcaci
Journal:  Case Rep Hematol       Date:  2015-12-16

7.  Skeletal involvement of hairy cell leukemia.

Authors:  Eric Durot; Anne Quinquenel; Jean-Charles Kleiber; Martine Patey; Arnaud Bazin; Alain Delmer
Journal:  Clin Case Rep       Date:  2018-07-02

8.  Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report.

Authors:  Shehab F Mohamed; Feryal Helmi; Susanna El-Akiki; Halima El Omri; Abdulqadir Nashwan; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2019-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.